title: Trichomegaly of eyelashes after treatment with erlotinib in carcinoma pancreas.
abstract: Epidermal growth factor receptor (EGFR) inhibitors have been widely used for the treatment of epithelial malignancies. A wide spectrum of skin toxicities have been described in patients receiving EGFR inhibitors. Trichomegaly, especially of the eyelashes is a rare side effect of this therapy. We report a case of trichomegaly of eyelashes in a 39-year-old male, a case of carcinoma pancreas. This side-effect of these medications gives prospects as a therapy to stimulate the growth of hair.
authors.affiliation: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
authors.forename: Varun
authors.initials: V
authors.lastname: Goel
authors.affiliation: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
authors.forename: Shubhra
authors.initials: S
authors.lastname: Raina
authors.affiliation: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
authors.forename: D
authors.initials: D
authors.lastname: Chandragouda
authors.affiliation: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
authors.forename: Sajjan
authors.initials: S
authors.lastname: Singh
authors.affiliation: Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
authors.forename: Vineet
authors.initials: V
authors.lastname: Talwar
authors.affiliation: Department of Pathology, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi, India.
authors.forename: Nivedita
authors.initials: N
authors.lastname: Patnaik
keywords: Carcinoma pancreas; epidermal growth factor receptor; erlotinib; eyelashes; trichomegaly; tyrosine-kinase inhibitors
references.citation: J Clin Oncol. 2008 Jul 10;26(20):3460-2
references.pmid: 18612164
references.citation: J Clin Oncol. 2011 Jun 20;29(18):e532-3
references.pmid: 21483009
references.citation: Cutan Ocul Toxicol. 2010 Mar;29(1):62-6
references.pmid: 19954400
references.citation: Curr Oncol. 2011 Jun;18(3):145-6
references.pmid: 21655160
references.citation: Radiol Oncol. 2013 May 21;47(2):166-75
references.pmid: 23801914
references.citation: Ophthalmic Plast Reconstr Surg. 2007 Jan-Feb;23(1):65-6
references.pmid: 17237698